症状性腹主动脉瘤EVAR长期结果与择期相当
本研究回顾性分析1998至2012年单中心使用Cook Zenith支架行EVAR的680例腹主动脉瘤患者,其中症状性137例。瘤颈解剖合适与更好的预后相关。
要点
- 症状性AAA的EVAR术后30天死亡率是无症状者的近4倍(6.6% vs 1.5%)。
- 长期再干预率、临床成功率及总生存率在症状性与无症状AAA间无显著差异。
- 术前瘤颈解剖合适与更好的总生存等结局独立相关。
核心结论
- 症状性AAA的EVAR术后30天死亡率显著高于无症状AAA,但长期结局差异消失。
- 瘤颈解剖合适与更好的结局(包括总生存)独立相关,强调严格解剖选择的重要性。
研究设计与样本
- 单中心回顾性队列研究,纳入1998至2012年连续接受Cook Zenith支架行EVAR的症状性和无症状AAA患者,排除破裂AAA。
- 共纳入680例患者,其中症状性AAA 137例。
临床怎么用
- 症状性AAA行EVAR需关注围手术期死亡风险,应加强术前内科优化。
- 严格解剖选择(瘤颈合适)对改善EVAR长期结局至关重要。
- 症状性AAA术后可能需要更密集的监测。
局限性
- 单中心回顾性研究,使用单一类型支架,结果外推需谨慎。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular aneurysm repair (EVAR) has been extensively study regarding elective and ruptured abdominal aortic aneurysm (AAA) repair. However, much less is known about EVAR of symptomatic nonruptured AAA, especially concerning the long-term results. The aim of this study was to assess the outcomes of EVAR of symptomatic AAA compared with asymptomatic AAA at a tertiary center using a single graft. METHODS: All consecutive patients treated for symptomatic and asymptomatic AAAs from 1998 to 2012 at our institution, using the Cook Zenith stent graft (Cook Europe A/S, Bjaeverskov, Denmark), were included in the study. Ruptured AAAs were excluded. Patients' charts were reviewed to obtain preoperative, intraoperative, and postoperative data. All available imaging was reviewed. Life tables were constructed to assess for overall and late AAA-related survival, clinical success, and endoleak freedom. RESULTS: There were 680 patients included (137 symptomatic AAAs). No difference in technical success rate (96.1% for asymptomatic AAAs vs 94.9% for symptomatic AAAs) was present (P = .477). Thirty-day mortality was more common in symptomatic AAAs (6.6% vs 1.5% for asymptomatic AAAs; P = .002). Freedom from reinterventions was 72% ± 3% for asymptomatic AAAs vs 73% ± 5% for symptomatic AAAs (P = .785) at 10 years postoperatively. There was no difference in primary (P = .300) or secondary (P = .099) clinical success between groups, although there was higher assisted clinical success (P = .023) for asymptomatic AAAs compared with symptomatic AAAs. Persistent late clinical failure was similar in both groups (14.2% for asymptomatic AAAs vs 15.3% for symptomatic AAAs; P = .732). Freedom from late AAA-related death was higher (P = .016) for asymptomatic AAAs compared with symptomatic AAAs, but the differences disappeared when the first 30 days were disregarded. Overall survival (P = .687) was similar in both groups. An adequate aneurysm neck preoperatively conferred a better outcome in end points including overall survival. CONCLUSIONS: Symptomatic AAAs have an almost quadrupled 30-day mortality compared with asymptomatic AAAs, but the outcome differences fade in the long term. An adequate aneurysm neck was associated with better outcomes including overall survival independent of the initial presentation of the AAA. These results suggest the need of improving the identification of symptomatic patients requiring preoperative medical optimization. However, this is often limited by the acute need of the procedure, and more intensive postoperative monitoring may have greater potential. Independently, a strict anatomic selection for infrarenal EVAR is of paramount importance for the long-term outcome.
引用
- Abdulrasak M, Sonesson BJ, Vaccarino R, et al. Endovascular aneurysm repair for symptomatic abdominal aortic aneurysms has comparable results to elective repair in the long term. J Vasc Surg. 2020. PMID: 32305386. doi:10.1016/j.jvs.2020.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。